V004-5571 Screening compound: N-[1-(3-chlorophenyl)-4-(4-chlorophenyl)-1H-imidazol-2-yl]-2-[1-(4-fluorophenyl)-N-[(oxolan-2-yl)methyl]formamido]acetamide

V004-5571 Screening compound: N-[1-(3-chlorophenyl)-4-(4-chlorophenyl)-1H-imidazol-2-yl]-2-[1-(4-fluorophenyl)-N-[(oxolan-2-yl)methyl]formamido]acetamide
V004-5571 Screening compound: N-[1-(3-chlorophenyl)-4-(4-chlorophenyl)-1H-imidazol-2-yl]-2-[1-(4-fluorophenyl)-N-[(oxolan-2-yl)methyl]formamido]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V004-5571
N-[1-(3-chlorophenyl)-4-(4-chlorophenyl)-1H-imidazol-2-yl]-2-[1-(4-fluorophenyl)-N-[(oxolan-2-yl)methyl]formamido]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V004-5571

Molecular Formula

C29H25Cl2FN4O3 (C29 H25 Cl2 FN4 O3)

Compound Name

N-[1-(3-chlorophenyl)-4-(4-chlorophenyl)-1H-imidazol-2-yl]-2-[1-(4-fluorophenyl)-N-[(oxolan-2-yl)methyl]formamido]acetamide

IUPAC name

N-[1-(3-chlorophenyl)-4-(4-chlorophenyl)-1H-imidazol-2-yl]-2-[1-(4-fluorophenyl)-N-[(oxolan-2-yl)methyl]formamido]acetamide

SMILES

O=C(CN(CC1OCCC1)C(c(cc1)ccc1F)=O)Nc1nc(-c(cc2)ccc2Cl)cn1-c1cccc(Cl)c1

InChI

InChI=1S/C29H25Cl2FN4O3/c30-21-10-6-19(7-11-21)26-17-36(24-4-1-3-22(31)15-24)29(33-26)34-27(37)18-35(16-25-5-2-14-39-25)28(38)20-8-12-23(32)13-9-20/h1,3-4,6-13,15,17,25H,2,5,14,16,18H2,(H,33,34,37)/t25-/m1/s1

InChI Key

SCMGQUNKQDAWNR-RUZDIDTESA-N

MDL Number (MFCD)

MFCD19823686

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

567.45

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.882

Distribution Coefficient, logD

5.882

Water Solubility, LogSw

-6.16

Polar Surface Area

61.047

Acid Dissociation Constant (pKa)

12.16

Base Dissociation Constant (pKb)

2.71

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

20.70

V004-5571 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

MCL1 Targeted Library (12200 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic

References: we are preparing a list of scientific research reports with V004-5571 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V004-5571?
Check Price and Availability of V004-5571, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V004-5571 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V004-5571
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V004-5571
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V004-5571 available by request